Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma

Epidermal growth factor receptor (EGFR) and tumour growth factor alpha (TGFα) are frequently overexpressed in renal cell carcinoma (RCC) yet responses to single-agent EGFR inhibitors are uncommon. Although von Hippel–Lindau (VHL) mutations are predominant, RCC also develops in individuals with tuber...

Descripción completa

Detalles Bibliográficos
Autores principales: Gemmill, R M, Zhou, M, Costa, L, Korch, C, Bukowski, R M, Drabkin, H A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361810/
https://www.ncbi.nlm.nih.gov/pubmed/15956968
http://dx.doi.org/10.1038/sj.bjc.6602646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361810/
https://www.ncbi.nlm.nih.gov/pubmed/15956968
http://dx.doi.org/10.1038/sj.bjc.6602646

Ejemplares similares